BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 18477793)

  • 21. CT screening for lung cancer.
    Dehavenon A
    N Engl J Med; 2007 Feb; 356(7):745-6; author reply 746-7. PubMed ID: 17310515
    [No Abstract]   [Full Text] [Related]  

  • 22. Lung cancer screening debate.
    Gould MK
    Chest; 2003 Feb; 123(2):653-4; author reply 654-5. PubMed ID: 12593410
    [No Abstract]   [Full Text] [Related]  

  • 23. Computed Tomography Screening for Lung Cancer: A High-Value Proposition?
    Roth JA; Ramsey SD
    JAMA; 2016 Jan; 315(1):77-8. PubMed ID: 26746460
    [No Abstract]   [Full Text] [Related]  

  • 24. Clearing the air: steps for lung cancer screening success.
    Jokerst C; Oliva I; Mohammed TL
    Curr Probl Diagn Radiol; 2015; 44(2):113-7. PubMed ID: 25541106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential conflict of interest.
    Grannis FW
    Lung Cancer; 2002 Oct; 38(1):103-4; discussion 105. PubMed ID: 12367803
    [No Abstract]   [Full Text] [Related]  

  • 26. Tobacco money at the University of California.
    Glantz SA
    Am J Respir Crit Care Med; 2005 May; 171(10):1067-9. PubMed ID: 15879426
    [No Abstract]   [Full Text] [Related]  

  • 27. Screening for cancer with computed tomography.
    Swensen SJ
    BMJ; 2003 Apr; 326(7395):894-5. PubMed ID: 12714453
    [No Abstract]   [Full Text] [Related]  

  • 28. Lung cancer screening: who will pick up the tab?
    Grannis FW
    Chest; 2002 May; 121(5):1388-90. PubMed ID: 12006414
    [No Abstract]   [Full Text] [Related]  

  • 29. Who is buying bioethics research?
    Sharp RR; Scott AL; Landy DC; Kicklighter LA
    Am J Bioeth; 2008 Aug; 8(8):54-8; discussion W1-2. PubMed ID: 18802867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Our conflicted medical journals.
    N Y Times Web; 2006 Jul; ():WK11. PubMed ID: 16906684
    [No Abstract]   [Full Text] [Related]  

  • 31. Conflict of interest: in the eye of the beholder?
    Chabner BA
    Oncologist; 2008 Mar; 13(3):212-3. PubMed ID: 18378530
    [No Abstract]   [Full Text] [Related]  

  • 32. AACR issues statement on the proposed tobacco settlement.
    J Natl Cancer Inst; 1997 Sep; 89(17):1259. PubMed ID: 9293915
    [No Abstract]   [Full Text] [Related]  

  • 33. Changing conclusions on secondhand smoke in a sudden infant death syndrome review funded by the tobacco industry.
    Tong EK; England L; Glantz SA
    Pediatrics; 2005 Mar; 115(3):e356-66. PubMed ID: 15741361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early Lung Cancer Action Project.
    Drury NE; Brown I; Dalrymple-Hay MJ; Delany DJ; Halson P
    Lancet; 1999 Oct; 354(9185):1206. PubMed ID: 10513731
    [No Abstract]   [Full Text] [Related]  

  • 35. Medical reviews face criticism over lapses.
    Armstrong D
    Wall St J (East Ed); 2006 Jul; ():B1, B2. PubMed ID: 16909499
    [No Abstract]   [Full Text] [Related]  

  • 36. Tough-talking journal editor faces accusations of leniency.
    McNeil DG
    N Y Times Web; 2006 Aug; ():F1, F3. PubMed ID: 16906685
    [No Abstract]   [Full Text] [Related]  

  • 37. Surgery journal threatens ban for authors' hidden conflicts.
    Armstrong D
    Wall St J (East Ed); 2005 Dec; ():B1, B2. PubMed ID: 16502542
    [No Abstract]   [Full Text] [Related]  

  • 38. Science on trial: conflicts of interest jeopardize scientific integrity and public health.
    Krimsky S
    Genewatch; 2003; 16(5):3-6. PubMed ID: 15025119
    [No Abstract]   [Full Text] [Related]  

  • 39. Clarifying Assumptions and Outcomes in Cost-effectiveness Analyses.
    ten Haaf K; de Koning HJ
    JAMA Oncol; 2016 Feb; 2(2):277-8. PubMed ID: 26869001
    [No Abstract]   [Full Text] [Related]  

  • 40. Clarifying Assumptions and Outcomes in Cost-Effectiveness Analyses--Reply.
    Goffin JR; Flanagan WM; Evans WK
    JAMA Oncol; 2016 Feb; 2(2):278-9. PubMed ID: 26869003
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.